GTX medical & NeuroRecovery Technologies merge to create leading neurostimulation company for SCI

22. October 2019

|In Portfolio News

|By eazee-designstudio

GTX medical and NeuroRecovery Technologies today announced their merger to create a leading global company committed to developing novel neuromodulation therapies to improve functional recovery of people with Spinal Cord Injuries (SCI). The merged entity will be known as GTX medical BV. The Christopher & Dana Reeve Foundation will be a shareholder in the merged company, alongside current investors including LSP, Inkef, Wellington Partners and GIMV. Ian Curtis will join the Board of Directors.